MedTrace Logo

Transcranial Photobiomodulation for Adult ADHD

NCT05752422 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-03-02

No results posted yet for this study

Summary

This study aims to assess the behavioral as well cognitive changes in ADHD symptoms in terms of improvement of inhibitory control and attention in adults with ADHD

Conditions

  • ADHD

Interventions

DEVICE

Niraxx G1 Headband Device including sham

Exploring effect of active t-PBM delivered by Niraxx G1 Headband versus sham condition

Sponsors & Collaborators

  • CNS Onlus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2024-06-30
Completion
2024-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752422 on ClinicalTrials.gov